Jason K Molitoris (Jason Molitoris)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Prostate Cancer

Dna Damage Response

Top Venues

Journal of clinical imaging science

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of applied clinical medical physics

This page only lists publications with an associated author ORCID identifier.

Publications

ByongYong Yi, Jenna Jatczak, Wei Deng, Yannick P Poirier, Weiguang Yao, Matthew E Witek, Jason K Molitoris, Mark J Zakhary, Baoshe Zhang, Nrusingh C Biswal, Matthew J Ferris, Sina Mossahebi
Is noncoplanar plan more robust to inter-fractional variations than coplanar plan in treating bilateral HN tumors with pencil-beam scanning proton beams? Journal of applied clinical medical physics (2023)
Gregory S Alexander, Ariel Eve Pollock, Danielle Arons, Matthew J Ferris, Jason K Molitoris, William F Regine, Matthew E Witek
Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy. Journal of clinical imaging science 13 (2023)
Matthew P Deek, Kim Van der Eecken, Philip Sutera, Rebecca A Deek, Valérie Fonteyne, Adrianna A Mendes, Karel Decaestecker, Ana Ponce Kiess, Nicolaas Lumen, Ryan Phillips, Aurélie De Bruycker, Mark Mishra, Zaker Rana, Jason K Molitoris, Bieke Lambert, Louke Delrue, Hailun Wang, Kathryn Lowe, Sofie L J Verbeke, Jo Van Dorpe, Renée Bultijnck, Geert Villeirs, Kathia De Man, Filip Ameye, Daniel Y Song, Theodore DeWeese, Channing J Paller, Felix Y Feng, Alexander W Wyatt, Kenneth J Pienta, Maximillian Diehn, Soren M Bentzen, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Emmanuel S Antonarakis, Tamara L Lotan, Alejandro Berlin, Shankar Siva, Piet Ost, Phuoc T Tran
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)